GO:2000236 negative regulation of tRNA processing: RNA Metabolism Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:2000236 (negative regulation of tRNA processing) describes any process that stops, prevents, or reduces the frequency, rate or extent of tRNA processing, also called negative regulation of tRNA maturation.
• tRNA processing includes 5-prime leader and 3-prime trailer removal, intron splicing, nucleotide modification, and CCA addition, and each step can be negatively regulated.
• Aminoacyl-tRNA synthetases can restrain tRNA-related steps through non-catalytic protein-protein interactions, linking tRNA processing control to angiogenesis and gene expression.
• RNA polymerase III transcription factors TFIIIB, TFIIIC and the MAF1 repressor set the upstream supply of tRNA transcripts that feed into processing.
• A mitochondrial tRNA processing enzyme acts as a key regulator of the mitochondrial unfolded protein response, showing that negative regulation of tRNA processing is integrated with stress signaling.
• CRISPR knockout, point-mutation, knock-in and overexpression models allow causal testing of candidate negative regulators of tRNA processing in disease contexts such as cancer and immune disorders.
Description
GO:2000236, negative regulation of tRNA processing, is a biological_process term in the Gene Ontology that captures any mechanism which stops, prevents, or reduces the frequency, rate or extent of tRNA processing, a process also referred to as negative regulation of tRNA maturation. tRNA processing is the series of maturation events that convert primary tRNA transcripts into functional tRNAs, and its negative regulation provides a layer of control over the cellular tRNA pool and therefore over translation. Because tRNA abundance and modification status influence protein synthesis, stress responses and cell fate, understanding how tRNA processing is restrained is relevant to basic RNA biology and to human disease. The term is mechanistically broad: negative regulation can occur at the level of RNA polymerase III transcription of tRNA genes, at endonucleolytic and exonucleolytic trimming of tRNA precursors, at splicing of intron-containing tRNAs, at nucleotide modification, and at CCA addition. Non-catalytic activities of aminoacyl-tRNA synthetases and other RNA-binding proteins can also reduce the efficiency of tRNA maturation steps without directly cleaving RNA. This makes GO:2000236 a useful annotation target for studies that perturb tRNA biogenesis and then measure downstream effects on translation and signaling. For researchers, GO:2000236 matters because it connects RNA processing control to physiological outputs such as angiogenesis, antiviral immunity and mitochondrial proteostasis. Experimental systems that manipulate candidate negative regulators, including CRISPR-based knockout and overexpression models, allow direct tests of whether a gene causally limits tRNA processing. This article summarizes the definition, mechanisms, key genes, disease links and research methods for GO:2000236 using only verified published literature.
negative regulation of tRNA processing At A Glance
| GO ID | GO:2000236 |
|---|---|
| GO term | negative regulation of tRNA processing |
| Ontology | biological_process |
| Synonym | negative regulation of tRNA maturation |
| Definition | Any process that stops, prevents, or reduces the frequency, rate or extent of tRNA processing. |
| Major function | Restrains tRNA maturation to control the cellular tRNA pool and downstream translation. |
| Biological context | tRNA biogenesis, RNA polymerase III transcription, mitochondrial proteostasis and stress signaling. |
| Related processes | tRNA processing (GO:0008033), regulation of transcription by RNA polymerase III, aminoacyl-tRNA synthetase signaling. |
| Representative regulators | MAF1, TFIIIB and TFIIIC subunits, mitochondrial tRNA processing enzymes, non-catalytic aminoacyl-tRNA synthetases. |
What Is GO:2000236?
In plain terms, GO:2000236 describes the brakes on tRNA maturation. The QuickGO definition states that it is any process that stops, prevents, or reduces the frequency, rate or extent of tRNA processing. Its synonym is negative regulation of tRNA processing, also expressed as negative regulation of tRNA maturation. The term is a biological_process and is the inverse of positive regulation of tRNA processing. It does not describe the processing reactions themselves, but the regulatory inputs that slow or suppress them, which may act on transcription of tRNA genes, on precursor trimming, on splicing, on modification, or on the stability and availability of processing factors.
Why Is negative regulation of tRNA processing Important in Cell Biology?
Negative regulation of tRNA processing is important because tRNA maturation is a rate-limiting input into translation, and its restraint can reshape the proteome during stress, immune activation and mitochondrial dysfunction. Because aminoacyl-tRNA synthetases and RNA polymerase III factors sit at the interface of tRNA supply and signaling, negative regulation of tRNA processing is also a node where metabolism, angiogenesis and antiviral responses converge. Studying GO:2000236 therefore helps explain how cells tune translation without globally shutting down RNA synthesis, and it provides candidate mechanisms for diseases in which tRNA biology is perturbed.
• Controls the available pool of mature tRNAs and therefore the capacity for protein synthesis.
• Links RNA polymerase III transcription factors TFIIIB and TFIIIC and the MAF1 repressor to downstream tRNA maturation.
• Involves non-catalytic regulation by aminoacyl-tRNA synthetases, connecting tRNA processing to angiogenesis and gene expression control.
• A mitochondrial tRNA processing enzyme regulates the mitochondrial unfolded protein response, tying GO:2000236 to proteostasis.
• Provides a mechanistic entry point for understanding how cells adapt translation during antiviral immune responses.
• Relevant to cancer biology, where altered tRNA processing and hepatocyte-derived signals influence tumor progression.
• Supports interpretation of single-cell and bulk RNA sequencing datasets in inflammatory diseases such as rheumatoid arthritis.
• Offers a framework for CRISPR screens that test negative regulators of tRNA maturation.
• Helps explain how nucleotide modifications on related RNA species can influence processing efficiency.
• Guides design of experiments that separate transcriptional from post-transcriptional control of tRNA biogenesis.
What Happens During negative regulation of tRNA processing?
Upstream restraint of tRNA gene transcription
In simple terms: The cell can slow the production of tRNA precursor molecules before they are even made.
Negative regulation of tRNA processing can begin at the level of RNA polymerase III transcription, because the amount of primary tRNA transcript sets the substrate available for maturation. The general transcription factors TFIIIB and TFIIIC are required for RNA polymerase III recruitment to tRNA genes, and the MAF1 protein acts as a repressor of this transcription program. When MAF1 or associated factors limit tRNA gene output, the downstream processing machinery receives fewer precursors, effectively reducing the rate of tRNA maturation. This tier of control is a bona fide negative regulation of tRNA processing because it reduces the frequency or extent of the processing events that follow.
Inhibition of precursor trimming and end processing
In simple terms: Enzymes that cut tRNA precursors into their mature ends can be blocked or slowed.
tRNA maturation requires removal of 5-prime leader and 3-prime trailer sequences by endonucleases and exonucleases, and negative regulation can act by limiting the activity or availability of these enzymes. A mitochondrial tRNA processing enzyme has been identified as a key regulator of the mitochondrial unfolded protein response, demonstrating that the trimming step is not merely housekeeping but is integrated with stress signaling. When such processing enzymes are restrained, unprocessed or partially processed tRNA species accumulate, and the cell can use this as a signal to adjust mitochondrial and cellular stress programs. This illustrates how negative regulation of tRNA processing can be a deliberate regulatory output rather than a passive failure of maturation.
Non-catalytic control by aminoacyl-tRNA synthetases
In simple terms: Some tRNA-related enzymes can put the brakes on processing without doing their classic chemical reaction.
Aminoacyl-tRNA synthetases are best known for charging tRNAs with amino acids, but they also regulate gene expression through non-catalytic interactions with RNA and protein partners. These non-catalytic functions can influence tRNA-related steps and broader RNA regulatory networks, providing a mechanism by which negative regulation of tRNA processing is coupled to signaling. Aminoacyl-tRNA synthetases also regulate angiogenesis, showing that their non-catalytic activities have physiological consequences beyond translation. Thus, negative regulation of tRNA processing can be executed by proteins that do not directly cleave or modify tRNA precursors but instead sequester or modulate processing factors.
Modification-dependent effects on processing efficiency
In simple terms: Chemical marks on RNA can change how efficiently processing enzymes recognize their targets.
Nucleotide modifications can alter RNA processing, as shown for N4-acetylcytidine modification of primary microRNAs in cancer cells, where the modification affects processing. Although that study concerns microRNA rather than tRNA, it establishes the principle that RNA modifications can modulate processing efficiency in a regulated manner. By analogy, negative regulation of tRNA processing can involve modification-dependent changes that reduce recognition or cleavage of tRNA precursors, thereby lowering the rate of maturation. This connects GO:2000236 to the broader field of epitranscriptomic control of RNA processing.
Integration with immune and stress signaling
In simple terms: The brakes on tRNA processing are wired into the cell's alarm systems.
Dynamic regulation of TBK1 lactylation shapes antiviral immune responses, illustrating how post-translational modification of a signaling kinase can rewire RNA-related and immune outputs. Negative regulation of tRNA processing can be embedded in such signaling because tRNA maturation status feeds into stress and immune programs. The mitochondrial unfolded protein response is directly regulated by a tRNA processing enzyme, providing a concrete example of how tRNA processing control is integrated with cellular stress signaling. Together, these findings position GO:2000236 as a regulatory hub that connects RNA maturation to immunity and proteostasis.
Key Genes Involved in GO:2000236 negative regulation of tRNA processing
The following genes and proteins have been implicated in tRNA processing, its negative regulation, or closely related RNA processing and signaling pathways in the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MAF1 | Repressor of RNA polymerase III transcription, limiting tRNA precursor supply | Candidate negative regulator upstream of tRNA processing |
| TFIIIB subunits | General transcription factors required for RNA polymerase III tRNA gene transcription | Targets for tuning tRNA precursor levels |
| TFIIIC subunits | General transcription factors that recognize tRNA gene promoters | Modulating tRNA gene output and downstream maturation |
| Mitochondrial tRNA processing enzyme | Key regulator of the mitochondrial unfolded protein response | Links tRNA processing to mitochondrial proteostasis |
| Aminoacyl-tRNA synthetases | Non-catalytic regulation of gene expression and angiogenesis | Connects tRNA biology to signaling and vascular biology |
| TBK1 | Signaling kinase whose lactylation shapes antiviral immunity | Context for immune regulation intersecting RNA biology |
| PRP19 | Spliceosome-associated factor increased in hepatocytes during hepatocarcinogenesis | Example of RNA processing machinery linked to cancer |
| HBEGF | Growth factor expressed in fibroblast subsets in rheumatoid arthritis | Illustrates single-cell RNA sequencing discovery of disease-associated genes |
| NAT10-related machinery | N4-acetylcytidine modification of primary microRNAs affecting processing | Model for modification-dependent processing control |
| RNA polymerase III | Transcribes tRNA genes to produce precursors | Upstream node for negative regulation of tRNA processing |
| Processing endonucleases | Cleave tRNA precursor leaders and trailers | Potential targets of negative regulation |
| Processing exonucleases | Trim tRNA precursor ends to mature termini | Potential targets of negative regulation |
| tRNA splicing factors | Remove introns from intron-containing tRNA precursors | Contribute to maturation control |
| tRNA modification enzymes | Install chemical modifications that affect processing and function | Modification-dependent regulation of processing |
| CCA-adding enzyme | Adds the 3-prime CCA terminus to mature tRNAs | Terminal maturation step subject to regulation |
| Stress-responsive kinases | Relay stress signals that can impinge on RNA processing | Connect signaling to tRNA maturation control |
| Spliceosome components | Participate in RNA processing and are linked to cancer | Broader RNA processing context for GO:2000236 |
How Is negative regulation of tRNA processing Regulated?
Negative regulation of tRNA processing is itself regulated at multiple levels. Upstream, RNA polymerase III transcription factors TFIIIB and TFIIIC and the MAF1 repressor control the supply of tRNA precursors, so changes in their activity alter the substrate available for processing. Downstream, the activity and availability of tRNA processing enzymes determine how efficiently precursors are matured, and at least one mitochondrial tRNA processing enzyme is a key regulator of the mitochondrial unfolded protein response, meaning that stress signaling can feed back onto processing. Non-catalytic activities of aminoacyl-tRNA synthetases add another regulatory layer by modulating RNA and protein partners without direct catalysis. In immune contexts, post-translational modifications such as TBK1 lactylation can reshape signaling networks that intersect with RNA biology. Together, these inputs allow the cell to slow tRNA maturation in response to transcriptional, metabolic and stress cues.
negative regulation of tRNA processing and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PRP19 | Hepatocarcinogenesis and B cell dysfunction | Hepatocyte-specific knockout or overexpression in liver cancer models |
| Mitochondrial tRNA processing enzyme | Mitochondrial unfolded protein response and proteostasis | Knockout and rescue in mitochondrial stress models |
| TBK1 | Antiviral immunity and lactylation-dependent signaling | Point-mutation knock-in of lactylation sites |
| Aminoacyl-tRNA synthetases | Angiogenesis and vascular biology | Endothelial overexpression and knockout models |
| HBEGF | Rheumatoid arthritis remission and fibroblast subsets | Single-cell guided knockout in fibroblast models |
Cancer and RNA processing dysregulation
Altered RNA processing is a hallmark of cancer, and increased PRP19 in hepatocytes impedes B cell function to promote hepatocarcinogenesis, showing that RNA processing machinery can drive tumor-promoting microenvironments. Modification-dependent control of primary microRNA processing in cancer cells further demonstrates that processing steps are tunable and can be co-opted during malignancy. Because negative regulation of tRNA processing controls the tRNA pool, its perturbation may contribute to the translational reprogramming observed in tumors. These findings support investigating GO:2000236-related genes as candidate modifiers of cancer biology.
Mitochondrial proteostasis and stress-related disease
A tRNA processing enzyme is a key regulator of the mitochondrial unfolded protein response, directly linking tRNA maturation control to mitochondrial proteostasis. When mitochondrial tRNA processing is impaired or negatively regulated, the resulting stress signals can influence cell survival and metabolic adaptation. This connection suggests that GO:2000236 may be relevant to disorders in which mitochondrial protein folding stress contributes to pathology. Experimental manipulation of the processing enzyme can therefore be used to probe mitochondrial stress responses.
Immune and inflammatory conditions
Dynamic regulation of TBK1 lactylation shapes antiviral immune responses, indicating that post-translational control of signaling kinases is central to immunity and can intersect with RNA regulatory networks. In rheumatoid arthritis, integration of single-cell and bulk RNA sequencing identified HBEGF+ fibroblasts associated with remission, illustrating how RNA-level analyses reveal disease-relevant cell states. Although these studies do not directly prove a role for tRNA processing in these diseases, they provide the immunological and inflammatory context in which negative regulation of tRNA processing may operate. This makes GO:2000236 a plausible node for future studies of immune-metabolic crosstalk.
Vascular and angiogenic processes
Aminoacyl-tRNA synthetases regulate angiogenesis through both catalytic and non-catalytic mechanisms, connecting tRNA-related biology to vascular remodeling. Non-catalytic regulation of gene expression by these enzymes provides a mechanism by which tRNA processing control could influence endothelial and stromal cell behavior. Because negative regulation of tRNA processing can modulate the tRNA pool, it may indirectly affect the translational capacity of angiogenic cells. This positions GO:2000236 within the broader interface of RNA biology and vascular disease.
From negative regulation of tRNA processing-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene a negative regulator of tRNA processing? | CRISPR knockout followed by tRNA processing assays |
| Does a specific residue control negative regulation? | Point-mutation knock-in of the candidate residue |
| Does a disease-associated variant alter tRNA processing? | Knock-in of the variant and comparison to wild type |
| Where does the regulator localize and interact? | Tagged knock-in for imaging and immunoprecipitation |
| Does increased dosage of the regulator reduce tRNA maturation? | Overexpression cell model with tRNA processing readouts |
| Which pathways buffer loss of the regulator? | CRISPR library screening and bioinformatics analysis |
How to Study the negative regulation of tRNA processing Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA sequencing | Abundance of precursor and mature RNAs | Detecting processing changes after perturbation |
| tRNA-specific profiling | Levels and ends of tRNA species | Assessing maturation efficiency |
| Proteomics | Protein interactions and complexes | Identifying non-catalytic regulators |
| Stress reporter assays | Mitochondrial unfolded protein response activity | Linking tRNA processing to proteostasis |
| Immune signaling assays | Antiviral pathway activation | Testing intersection with immunity |
| Single-cell RNA sequencing | Cell-type-specific gene expression | Discovering disease-associated cell states |
| Imaging of tagged proteins | Subcellular localization | Determining where regulation occurs |
| CRISPR library screening | Fitness and pathway dependencies | Finding modifiers of tRNA processing |
RNA sequencing and tRNA profiling
RNA sequencing can quantify precursor and mature RNA species and reveal changes in processing efficiency when candidate negative regulators are perturbed. In studies of RNA modification and processing, sequencing-based approaches identified how N4-acetylcytidine affects primary microRNA processing in cancer cells, providing a template for analogous tRNA studies. Bulk and single-cell RNA sequencing datasets have also been integrated to identify disease-associated cell states and genes, an approach that can be adapted to tRNA-related questions. These methods help determine whether a regulator acts on precursor abundance or on maturation steps.
Proteomics and interaction mapping
Proteomic and interaction studies can identify protein partners of tRNA processing enzymes and reveal non-catalytic regulatory complexes. Non-catalytic regulation of gene expression by aminoacyl-tRNA synthetases was established through such biochemical and interaction analyses. Mapping interactions between processing enzymes and signaling proteins can show how negative regulation of tRNA processing is wired into cellular networks. These approaches complement genetic perturbation by defining the molecular context of regulation.
Stress and signaling assays
Because a mitochondrial tRNA processing enzyme regulates the mitochondrial unfolded protein response, stress reporter assays are valuable for studying negative regulation of tRNA processing. Antiviral immune responses can be monitored in systems where signaling kinases such as TBK1 are modified, linking RNA biology to immune output. Combining stress assays with genetic perturbation allows researchers to test whether changes in tRNA processing cause or merely correlate with stress phenotypes. Such assays are essential for establishing causality in GO:2000236 research.
Imaging and localization
Tagged knock-in models enable imaging of processing factors and their localization within cells and organelles. Localization data help determine whether negative regulation occurs in the nucleus, cytosol or mitochondria, which is critical for interpreting tRNA processing phenotypes. Imaging can also reveal whether regulators sequester processing enzymes away from their substrates. These approaches provide spatial context that complements sequencing and proteomic data.
How CRISPR Can Be Used to Study GO:2000236 negative regulation of tRNA processing
Knockout
CRISPR knockout of candidate negative regulators allows direct testing of whether loss of the gene increases tRNA processing. For example, knocking out a mitochondrial tRNA processing enzyme can reveal its role in the mitochondrial unfolded protein response. Knockout of RNA polymerase III regulators such as MAF1 would be expected to alter tRNA precursor supply and downstream maturation. These models are essential for establishing causality in GO:2000236 research.
Point Mutation
Point-mutation knock-in can test whether specific residues are required for negative regulation. Lactylation site mutations in TBK1 have been used to dissect how post-translational modification shapes antiviral immune responses, providing a template for analogous studies of tRNA processing regulators. Such models help distinguish catalytic from non-catalytic functions, which is particularly relevant for aminoacyl-tRNA synthetases. They also allow precise testing of disease-associated variants.
Knock-in
Knock-in of tags or disease variants enables localization, interaction and functional studies of tRNA processing regulators. Tagged knock-in of processing enzymes can reveal where they act and which partners they engage. Knock-in of variants identified in disease cohorts can test whether they alter tRNA maturation. These models bridge genetic association and mechanistic understanding.
Overexpression
Overexpression of a candidate negative regulator can test whether increased dosage reduces tRNA processing. Aminoacyl-tRNA synthetases regulate angiogenesis, and overexpression models have been used to probe their non-catalytic functions. Overexpression combined with tRNA profiling can reveal whether a regulator limits maturation at the precursor or mature tRNA level. Such experiments complement loss-of-function studies to build a complete picture of GO:2000236.
How EDITGENE Supports negative regulation of tRNA processing Research
Researchers studying negative regulation of tRNA processing-related genes often need to determine whether a candidate gene is causally involved in controlling tRNA maturation, and whether that control affects disease-relevant phenotypes. EDITGENE provides the CRISPR cell models and screening services needed to move from correlation to causation in GO:2000236 research.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of tRNA processing research.
Frequently Asked Questions About negative regulation of tRNA processing
What is GO:2000236?
GO:2000236 is the Gene Ontology biological_process term for negative regulation of tRNA processing, defined as any process that stops, prevents, or reduces the frequency, rate or extent of tRNA processing, also called negative regulation of tRNA maturation.
What does negative regulation of tRNA processing mean in simple terms?
It means the cellular brakes on tRNA maturation, reducing how quickly or how often tRNA precursors are converted into mature tRNAs.
What genes are involved in negative regulation of tRNA processing?
Genes and proteins implicated include MAF1, TFIIIB and TFIIIC subunits, mitochondrial tRNA processing enzymes, and aminoacyl-tRNA synthetases with non-catalytic functions.
How is tRNA processing negatively regulated?
It can be regulated by limiting RNA polymerase III transcription of tRNA genes, by restraining processing enzymes, by non-catalytic protein interactions, and by modification-dependent effects on processing efficiency.
Why is negative regulation of tRNA processing important?
It controls the tRNA pool available for translation and is integrated with stress, immune and mitochondrial proteostasis signaling.
Is negative regulation of tRNA processing linked to cancer?
RNA processing dysregulation is observed in cancer, and increased PRP19 in hepatocytes promotes hepatocarcinogenesis, supporting investigation of processing control in tumors.
What diseases are associated with tRNA processing control?
Mitochondrial proteostasis disorders, cancer and immune or inflammatory conditions are contexts in which tRNA processing control has been studied or implicated.
What methods are used to study negative regulation of tRNA processing?
RNA sequencing, tRNA profiling, proteomics, stress reporter assays, imaging and CRISPR screening are commonly used.
How can CRISPR help study GO:2000236?
CRISPR knockout, point-mutation, knock-in and overexpression models allow causal testing of candidate regulators of tRNA processing.
What services does EDITGENE provide for tRNA processing research?
EDITGENE provides knockout, point-mutation, knock-in, overexpression cell models, CRISPR library screening and bioinformatics services for tRNA processing research.
Conclusion
GO:2000236, negative regulation of tRNA processing, defines the regulatory inputs that slow or suppress tRNA maturation, spanning RNA polymerase III transcription control, processing enzyme restraint, non-catalytic protein interactions and modification-dependent effects. Its integration with mitochondrial proteostasis, immune signaling and cancer biology makes it a compelling area for mechanistic and translational studies. CRISPR-based knockout, point-mutation, knock-in and overexpression models, combined with RNA sequencing, proteomics and screening, provide the tools needed to test causality and identify therapeutic opportunities.
References
- 1. Xie Y et al.. 2026. Dynamic regulation of TBK1 lactylation shapes antiviral immune responses.. Cell Mol Immunol 23(3):284-300 PMID: 41530535
- 2. Zhang H et al.. 2024. N4-acetylcytidine modifies primary microRNAs for processing in cancer cells.. Cell Mol Life Sci 81(1):73 PMID: 38308713
- 3. Chen N et al.. 2022. Identification of HBEGF+ fibroblasts in the remission of rheumatoid arthritis by integrating single-cell RNA sequencing datasets and bulk RNA sequencing datasets.. Arthritis Res Ther 24(1):215 PMID: 36068607
- 4. Mirando AC et al.. 2014. Regulation of angiogenesis by aminoacyl-tRNA synthetases.. Int J Mol Sci 15(12):23725-48 PMID: 25535072
- 5. Liu Z et al.. 2024. Increased PRP19 in Hepatocyte Impedes B Cell Function to Promote Hepatocarcinogenesis.. Adv Sci (Weinh) 11(46):e2407517 PMID: 39422063
- 6. Yao P et al.. 2014. Non-catalytic regulation of gene expression by aminoacyl-tRNA synthetases.. Top Curr Chem 344:167-87 PMID: 23536244
- 7. Graczyk D et al.. 2018. Regulation of tRNA synthesis by the general transcription factors of RNA polymerase III - TFIIIB and TFIIIC, and by the MAF1 protein.. Biochim Biophys Acta Gene Regul Mech 1861(4):320-329 PMID: 29378333
- 8. Held JP et al.. 2022. A tRNA processing enzyme is a key regulator of the mitochondrial unfolded protein response.. Elife 11 PMID: 35451962
